Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer

SAN DIEGO, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally inaccessible targets, today announced the app... Biopharmaceuticals, Personnel Vividion Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news